Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...
Keyboard shortcuts can supercharge your workflow - if you know what they are. Here are the ones I recommend to every user.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback